Clinical trial
Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)
NCT00133237 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00133237 |
|---|---|
| Title | Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN) |
| Official title | Prospective, Randomized Trial of the Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for the Treatment of Unprotected Left Main Coronary Artery Disease(ISAR-LEFT-MAIN) |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Collaborators | Technical University of Munich |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease |
| Intervention type | Device |
| Interventions | Sirolimus-eluting stent, Paclitaxel-eluting stent |
| Enrollment | 607 |
| Start date | Jul 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Aug 23, 2005 |
| Last update posted | Mar 15, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: